Utilization of recombinant activated factor VII for intracranial hematoma evacuation in coagulopathic nonhemophilic neurosurgical patients with normal international normalized ratios

Author： McClelland Shearwood   Won Eun   Lam Cornelius  

Publisher： Humana Press, Inc

ISSN： 1541-6933

Source： Neurocritical Care, Vol.7, Iss.2, 2007-10, pp. : 136-139

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Activated Recombinant Human Coagulation Factor VII Therapy for Intracranial Hemorrhage in Patients with Hemophilia A or B with Inhibitors

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 2, 1999-03 ,pp. : 93-98

Karger

Access to resources Recommend Favorite

Successful Management of Massive Intraperitoneal Bleeding in a Hemophilia A Patient with Inhibitor by Surgical Debridement of the Incomplete Hematoma and Administration of Recombinant Factor VIII and Activated Factor VII

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 35, Iss. 5, 2007-01 ,pp. : 405-407

Karger

Access to resources Recommend Favorite

Recombinant activated factor VII in paediatric cardiac surgery

By Egan Jonathan   Lammi Ahti   Schell David   Gillis Jonathan   Nunn Graham  

Intensive Care Medicine, Vol. 30, Iss. 4, 2004-04 ,pp. : 682-685

Springer Publishing Company

Access to resources Recommend Favorite

Ten‐year experience of recombinant activated factor VII use in surgical patients with congenital haemophilia with inhibitors or acquired haemophilia in Japan

By  

HAEMOPHILIA, Vol. 21, Iss. 3, 2015-05 ,pp. : 374-379

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Emerging Role of Recombinant-Activated Factor VII in Neurocritical Care

By Fewel Matthew E.   Park Paul  

Neurocritical Care, Vol. 1, Iss. 1, 2004-01 ,pp. : 19-30

Humana Press, Inc

Access to resources Recommend Favorite